Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revival of autochthonous adrenocortical stem cells in autoimmune Addison's disease (RoSA)
2009-018074-56Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tetracosactide hexaacetate in Addison's disease and hypoadrenocorticism, sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoints: Restoration of adrenocortical synthetic function and Safety of repeated Synacthen Depot stimulation. Started Mar 2010; status: completed.
02
Drugs
tetracosactide hexaacetate
03
Conditions
Addison's diseasehypoadrenocorticism
Beyond the preview
Go deeper on 2009-018074-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018074-56.